Journal
MAYO CLINIC PROCEEDINGS
Volume 92, Issue 1, Pages 159-172Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.mayocp.2016.10.019
Keywords
-
Categories
Funding
- Center for Individualized Medicine at Mayo Clinic
Ask authors/readers for more resources
Recent technological advances have radically changed genetic testing from an expensive and burdensome undertaking to a rapid and less costly option for many purposes. The utility of next-generation sequencing has been found to establish the diagnosis for hundreds of genetic disorders, to assess pharmacogenomic variants, and to identify treatable targets within malignant neoplasms. The ready availability of genomic information has led to the question of whether there would be clinical benefit of sequencing the genome of individuals who are not seeking a diagnosis, that is, genomic screening in generally healthy people, to provide anticipatory insights for their health care. Little research has been conducted in this area. We examine the considerable unresolved scientific and ethical issues encountered when considering whole-genome sequencing of healthy people. (C) 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available